SFJ Pharmaceuticals Group is a global specialty pharmaceutical company with an innovative pharmaceutical co-development model that provides an advantageous alternative to traditional pharma partnerships. SFJ’s unique partnering approach provides experienced clinical and medical professionals, clinical development resources and operational oversight and execution to accelerate late-phase drug development candidates across multiple indications and therapeutic areas. The result is pipeline acceleration for our partners.
SFJ Pharmaceuticals Group is staffed with a seasoned team of professionals with extensive experience in the global clinical development and regulatory approval of pharmaceutical products.
SFJ Pharmaceuticals Group has offices in the United States, Japan, Singapore, Korea, China, Spain and Germany.